• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT MITRACLIP SYSTEM STEERABLE GUIDE CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT MITRACLIP SYSTEM STEERABLE GUIDE CATHETER Back to Search Results
Catalog Number SGC0302
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Atrial Perforation (2511); Test Result (2695)
Event Date 01/15/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.A conclusive cause for the reported difficulties, and the relationship to the product, if any, cannot be determined.The reported patient effect of atrial septal defect requiring intervention as listed in the mitraclip system instructions for use, is a known possible complication associated with mitraclip procedures.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Event Description
This is filed on the steerable guide catheter to report the atrial septal defect requiring closure.It was reported that on (b)(6) 2019 this was a mitraclip procedure to treat grade 4 mixed etiology mitral regurgitation (mr).The mitral valve was accessed through the inter-atrial septum via the steerable guide catheter (sgc).Two mitraclips were implanted reducing mr grade to 1.The patient developed a right to left shunt resulting in hypoxia.The iatrogenic atrial septal defect was treated with an occluder device.The hypoxia resolved on (b)(6) 2019.The hospitalization was prolonged, but there was no adverse sequela.No additional information was provided.
 
Event Description
Subsequent to the previously filed report, additional information was received that the hypoxia and shunting was observed five days after the procedure.No additional information was provided.
 
Manufacturer Narrative
Internal file number - (b)(4).Correction to the date of event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM STEERABLE GUIDE CATHETER
Type of Device
STEERABLE GUIDE CATHETER
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key8628122
MDR Text Key145649584
Report Number2024168-2019-03969
Device Sequence Number1
Product Code DRA
Combination Product (y/n)N
PMA/PMN Number
K161985
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Remedial Action Other
Type of Report Initial,Followup
Report Date 06/10/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/21/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/18/2019
Device Catalogue NumberSGC0302
Device Lot Number80817U130
Was Device Available for Evaluation? No
Date Manufacturer Received05/31/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
CLIP DELIVERY SYSTEM; CLIP DELIVERY SYSTEM
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age69 YR
Patient Weight51
-
-